Status:
TERMINATED
Apple Respiratory Study
Lead Sponsor:
Apple Inc.
Collaborating Sponsors:
University of Washington
Conditions:
Acute Respiratory Infection
Coronavirus Infection
Eligibility:
All Genders
22+ years
Brief Summary
The Apple Respiratory Study, a collaboration between researchers at Apple Inc. (the "Study Sponsor" or "Sponsor") and the Seattle Flu Study team at the University of Washington (UW) (the "UW Study Tea...
Detailed Description
Initial Screening and Study enrollment will begin in 2021 among adults residing in the Greater Seattle area. Participants will be recruited and driven to the online Study Website managed by UW. If det...
Eligibility Criteria
Inclusion
- To participate in this Study, individuals must:
- Have access to an iPhone 6s or later with compatible iOS as defined by the Apple App Store.
- Have regular and reliable internet access
- Be willing to comply with all Study procedures, including regular use of the Apple Watch (daytime and nighttime), complete the REDCap and Apple Research app surveys, share data from required Apple Watch and iPhone sensors, and perform self-collected nasal swabs
- Be able to read and comprehend English
- Be able to provide informed consent without the use of a legally authorized representative
- Have a permanent mailing address in the greater Seattle area where Study materials can be mailed
- Be at least 22 years old at the time of consent
Exclusion
- To participate in this Study, individuals must not:
- Have previously tested positive for SARS-CoV-2 via PCR or antibody test
- Currently be enrolled in University of Washington Husky Coronavirus Testing, Household Observation Study, or any other Seattle Flu Study sub-Study
- Have received any vaccine for COVID-19 or have an upcoming appointment for at least one dose of any COVID-19 vaccine prior to Study consent
- Individuals also may be excluded from the Study once target participant counts have been achieved for certain demographics, comorbidity groups, and/or residence based on zip code
Key Trial Info
Start Date :
April 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 9 2021
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04912180
Start Date
April 6 2021
End Date
June 9 2021
Last Update
July 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98109